Product Images Bupropion Hydrochloride SR

Each tablet of this medicine contains 150mg of bupropion HCI USP. The usual dosage is indicated in the package insert along with the full prescribing information. This is an extended-release tablet that must be stored at 20° to 25°C (68° to 77°F), in a tightly sealed container that is light-resistant and child-resistant. The manufacturer of the medicine is Yichang Humanwell Oral Solid Dosage Plant, and it is distributed by Slate Run Pharmaceuticals LLC. It is advised not to use this medicine with other products that contain bupropion HCI.*

NDC 70436.058.01 is a drug called Twice-A-Day Reowy that contains 100mg of bupropion HCI in an extended-release tablet form. It is important to not use this drug with other medications that contain bupropion HCI. The usual dosage should be referenced in the package insert for full prescribing information. It should be stored out of the reach of children in a high, light-resistant container at 20-25°C (68-77°F). The drug is manufactured in China and distributed by Sae Run Pharmaceuticals in Ohio.*

NDC 70436.059.01 refers to Twice-A-Day Beauty by Bupropion HCI, which is an extended-release tablet that contains 150mg of bupropion HCI USP. Patients should not use this medication together with any other drugs containing bupropion HCI. The medication should be kept out of the reach of children and stored in a high, light-resistant container at a temperature of 20-25°C. The pharmacist should dispense it with the attached medication guide. For full prescribing information, refer to the package insert. The manufacturer is Yichang Humanwel Oral Solid Dosage Plant, located in Yichang, Hubel, China, and it is distributed by Sae Run Pharmaceuticals, LG, in Columbus, Ohio.*

This is a warning label found on a medication bottle for NDG 70436.069.02 R tablets containing 150 mg of buPROPion HCI. The tablets are extended-release and are to be taken twice daily after a meal. It is advised not to take this medication with other medicines containing bupropion HCL. The pharmacist is instructed to dispense with the attached medication guide. The label reminds users to keep this and all drugs out of children's reach and to store them in a container with a child-resistant closure. There is information on the manufacturer, dosage plan, and storage guidelines.*

This appears to be a medication label for extended-release tablets of buPROPrion HCI. The medication is meant to be taken twice a day, and caution is given to not use it with other medications containing bupropion. The label also warns to use it with the attached Medication Guide.*

This is a medication label for NOG T0436.060.01 Reonty, which contains 200mg of Bupropion HCl in extended-release tablets. The label warns not to take this medication with other drugs containing Bupropion HCl and instructs the pharmacist to dispense it with the attached medication guide. The recommended dosage can be found in the package insert, and all medications should be kept out of reach of children. Some characters are not legible.*

This appears to be a medication label or prescription. It includes a product code, dosage information, tablet type (extended-release), and other details related to the medication. However, due to garbled or incomplete text, it is difficult to provide a specific description.*